KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Interest Expenses (2016 - 2025)

Historic Interest Expenses for National Health Investors (NHI) over the last 15 years, with Q3 2025 value amounting to $13.8 million.

  • National Health Investors' Interest Expenses fell 785.19% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.3 million, marking a year-over-year decrease of 196.59%. This contributed to the annual value of $59.9 million for FY2024, which is 299.69% up from last year.
  • Latest data reveals that National Health Investors reported Interest Expenses of $13.8 million as of Q3 2025, which was down 785.19% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Interest Expenses ranged from a high of $15.2 million in Q4 2024 and a low of $10.2 million during Q1 2022
  • Over the past 5 years, National Health Investors' median Interest Expenses value was $14.0 million (recorded in 2023), while the average stood at $13.5 million.
  • As far as peak fluctuations go, National Health Investors' Interest Expenses tumbled by 2139.06% in 2022, and later surged by 3754.66% in 2023.
  • National Health Investors' Interest Expenses (Quarter) stood at $12.3 million in 2021, then rose by 1.33% to $12.4 million in 2022, then increased by 19.34% to $14.9 million in 2023, then increased by 2.61% to $15.2 million in 2024, then dropped by 9.67% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q3 2025, $15.0 million for Q2 2025, and $14.3 million during Q1 2025.